Study of Fluticasone/Formoterol/Glycopyrronium for the Treatment Chronic Obstructive Pulmonary Disease (TRIPLAR)
Condition(s):Chronic Obstructive Pulmonary DiseaseLast Updated:January 31, 2024Not yet recruiting
Include Studies Not Open or Pending
Condition(s):Chronic Obstructive Pulmonary DiseaseLast Updated:January 31, 2024Not yet recruiting
Condition(s):AsthmaLast Updated:March 6, 2024Recruiting
Condition(s):AsthmaLast Updated:March 7, 2024Recruiting
Condition(s):Moderate AsthmaLast Updated:January 5, 2024Not yet recruiting
Condition(s):COPD ExacerbationLast Updated:November 15, 2022Recruiting
Condition(s):Chronic Obstructive Pulmonary DiseaseLast Updated:March 18, 2024Recruiting
Condition(s):Pulmonary Disease, Chronic Obstructive (COPD)Last Updated:March 15, 2024Recruiting
Condition(s):Chronic Obstructive Pulmonary Disease (COPD)Last Updated:March 20, 2024Not yet recruiting
Condition(s):Chronic Obstructive Pulmonary DiseaseLast Updated:February 13, 2024Recruiting
Condition(s):COPD (Chronic Obstructive Pulmonary Disease)Last Updated:March 12, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.